Relationship Between Duodenal Histopathology and Strong Positive Tissue Transglutaminase Antibodies in Children with Celiac Disease

被引:1
作者
Dogan, Guzide [1 ]
Ayhan, Semin [2 ]
Yilmaz, Bilge [1 ]
Appak, Yeliz Cagan [1 ]
Dundar, Pinar Erbay [3 ]
Ecemis, Talat [4 ]
Unal, Fatih [5 ]
Kasirga, Erhun [1 ]
机构
[1] Celal Bayar Univ, Tip Fak, Cocuk Sagligi & Hastaliklari Anabilim Dali, Manisa, Turkey
[2] Celal Bayar Univ, Tip Fak, Patol Anabilim Dali, Manisa, Turkey
[3] Celal Bayar Univ, Tip Fak, Halk Sagligi Anabilim Dali, Manisa, Turkey
[4] Celal Bayar Univ, Tip Fak, Klin Mikrobiyol Anabilim Dali, Manisa, Turkey
[5] Dortcel Cocuk Hastanesi, Cocuk Hastaliklari Gastroenterol & Beslenme Dali, Bursa, Turkey
来源
GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS | 2015年 / 13卷 / 03期
关键词
Celiac disease; tissue transglutaminase antibody; duodenum; histopathology;
D O I
10.4274/jcp.81994
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: In celiac disease (CD) strong positive tissue transglutaminase antibody (TTGA) levels (> 100 U/A) have been shown to almost always indicate villous atrophy. The aim of this study is to determine the sufficiency of >= 100 U/A Ig A type TTGA levels for diagnosis of CD. Materials and Methods: Results from duodenum biopsy performed due to positive TTGA in 197 children were retrospectively examined. IgA TTGA levels had a positive value of > 18 U/A. Increases of 5 times or more than this threshold value (>= 100 U/A) are accepted as strong positivity. CD diagnosis was made according to ESPGHAN criteria. A modified Marsh stage >= 2 was accepted as significant for CD. Results: Of the cases, 129 were female (65.5%) and 68 were male (34.5%). Duodenum histopathology was compatible with Marsh 0 for 1 case (0.5%), Marsh 2 for 17 cases (8.6%), Marsh 3a for 41 (20.8%), Marsh 3b for 81 (41.4%) and Marsh 3c for 57 (28.9%). The TTGA levels of 64 of the 197 cases (32.5%) were >= 100 U/A. In cases with strong positivity for TTGA the duodenum histology was compatible with Marsh 3 (villous atrophy) for 63 and Marsh 0 (normal histology) for 1 case (type 1 diabetic and asymptomatic for CD). For Marsh 3c TTGA levels >= 100 U/A had a sensitivity of 85.96% (95% CI: 74.2-93.7%), specificity of 89.29% (95% CI: 82.9-93.8%), positive predictive value of 76.56% (95% CI: 64.3-86.2%) and negative predictive value of 93.9% (95% CI: 88.4-97.3%). Conclusions: This study showed that positive IgA TTGA levels (>= 100 U/A) were almost always accompanied by Marsh 3 duodenal histopathological changes. Diagnosis of CD without biopsy may miss certain accompanying diseases, however in some cases with advanced examinations CD may be diagnosed by pediatric gastroenterology specialists without endoscopy.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 50 条
  • [31] Autoantibodies against soluble and immobilized human recombinant tissue transglutaminase in children with celiac disease
    Agardh, D
    Dahlbom, I
    Daniels, T
    Lörinc, E
    Ivarsson, SA
    Lernmark, Å
    Hansson, T
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 41 (03) : 322 - 327
  • [32] Celiac disease diagnosis: transglutaminase, duodenal biopsy and genetic tests correlations
    Schesquini-Roriz, Katia Regina Pena
    Rodriguez, Gloria Maria Fraga
    Castellanos, Jocelyn Cristina Betancourt
    Martinez-Martinez, Laura
    Guerrero, Susana Boronat
    Rodrigo, Carlos
    Badell, Isabel
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [33] Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy
    Zingone, Fabiana
    Norman, Gary L.
    Smecuol, Edgardo
    Maniero, Daria
    Carroccio, Antonio
    Biagi, Federico
    Stefanolo, Juan P.
    Niveloni, Sonia
    Holmes, Geoffrey
    Villanacci, Vincenzo
    Santonicola, Antonella
    Bai, Julio C.
    Ciacci, Carolina
    DIGESTIVE AND LIVER DISEASE, 2025, 57 (02) : 609 - 615
  • [34] Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
    Stricker, Sebastian
    Rudloff, Silvia
    De Laffolie, Jan
    Zimmer, Klaus-Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [35] IgA anti-tissue transglutaminase antibodies and IgG antibodies against deamidated gliadin peptides as predictors of celiac disease
    Ortiz, Gonzalo
    Messere, Gabriela
    Toca, Maria del C.
    Fiorucci, Mirian
    Bigliardi, Roman
    Vidal, Jorge
    Reynoso, Ricardo
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (01): : 52 - 55
  • [36] Anti-tissue transglutaminase titers are associated with endoscopic findings and severity of mucosal damage in children with celiac disease
    Ziv-Baran, Tomer
    Dubov, Yulia
    Weinberger, Ronit
    Guz-Mark, Anat
    Shamir, Raanan
    Assa, Amit
    EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (01) : 263 - 269
  • [37] Anti-tissue transglutaminase titers are associated with endoscopic findings and severity of mucosal damage in children with celiac disease
    Tomer Ziv-Baran
    Yulia Dubov
    Ronit Weinberger
    Anat Guz-Mark
    Raanan Shamir
    Amit Assa
    European Journal of Pediatrics, 2021, 180 : 263 - 269
  • [38] Correlation Between IgA Tissue Transglutaminase Antibody Ratio and Histological Finding in Celiac Disease
    Alessio, Maria G.
    Tonutti, Elio
    Brusca, Ignazio
    Radice, Antonella
    Licini, Lisa
    Sonzogni, Aurelio
    Florena, Ada
    Schiaffino, Eugenio
    Marus, Wally
    Sulfaro, Sandro
    Villalta, Danilo
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2012, 55 (01) : 44 - 49
  • [39] Correlation between anti-tissue transglutaminase titres and villous abnormalities in celiac disease
    Verma, Anilk
    Singh, Prashant
    Kurray, Lalit
    Agnihotri, Abhishek
    Das, Prasenjit
    Sreenivas, Vishnubhatla
    Gupta, Siddharthdatta
    Makharia, Govindk
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 599 - 599
  • [40] Serological diagnosis of celiac disease: anti-gliadin peptide antibodies and tissue anti-transglutaminase.
    Piaggio, MV
    Demonte, AM
    Sihufe, G
    Garcilazo, S
    Esper, MC
    Wagener, M
    Aleanzi, M
    MEDICINA-BUENOS AIRES, 1999, 59 (06) : 693 - 697